Warning
Meitheal Pharmaceuticals Recalls Cetrorelix Acetate for Injection (Kit)
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0340-2026Drug / Pharmaceutical
Meitheal Pharmaceuticals Recalls Cetrorelix Acetate for Injection (Kit)
Meitheal Pharmaceuticals, Inc · Class II — Moderate Risk
Product Description
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Reason for Recall
Defective Delivery System: Missing or duplicated needles within the injection kit
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Meitheal Pharmaceuticals, Inc has recalled a pharmaceutical product that the FDA classified as Class II affecting 16,477 kits. The recall was initiated on February 9, 2026. Defective Delivery System: Missing or duplicated needles within the injection kit. It was distributed in U.S. Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.